Hepato-biliary and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Surg Endosc. 2024 May;38(5):2611-2621. doi: 10.1007/s00464-024-10757-3. Epub 2024 Mar 18.
Hepatic resection combined with intraoperative ablation has been described as a technical solution potentially widening the resectability rate of patients with colorectal liver metastases (CRLM). Nevertheless, the perioperative and oncological benefit provided by this combined approach remains unclear. We hypothesized that textbook outcome (TO), which is a composite measure achieved for patients for whom some desired health indicators are met, may help to refine the indications of this approach.
Patients submitted to hepatectomy with curative intent in combination with radiofrequency ablation or microwave ablation for CRLM ≤ 3 cm in two tertiary referral centers were included. TO was defined according to a recent definition for liver surgery based on a Delphi process including also the achievement of complete radiological response of the ablated lesion/s at 4 weeks.
Between 2015 and 2022, 112 patients were enrolled. Among them, 63 (56.2%) achieved a TO. According to multivariate analysis, minimally invasive (MI) approach (OR 2.72, 95% CI 0.99-7.48, p = 0.050), simultaneous CR resection (OR 0.28, 95% CI 0.11-0.70, p = 0.007), tumor burden score (OR 0.89, 95% CI 0.82-0.96, p = 0.004), and major hepatectomy (OR 0.12, 95% CI 0.03-0.52, p = 0.004) were significantly associated with the achievement of TO. Median overall survival was longer in those patients who were able to achieve a TO compared to those who did not.
The combination of hepatectomy and ablation constitutes a valuable solution in patients affected by multiple CRLM and it may provide, also using a MI approach, adequate perioperative and oncological outcomes, allowing to achieve TO, however, in a selected number of patients and depending on several factors including the burden of disease.
肝切除术联合术中消融已被描述为一种技术解决方案,可能扩大结直肠癌肝转移(CRLM)患者的可切除率。然而,这种联合方法的围手术期和肿瘤学益处仍不清楚。我们假设,教科书结果(TO)是一种综合衡量标准,适用于满足某些期望健康指标的患者,可能有助于细化该方法的适应证。
本研究纳入了在两个三级转诊中心接受以治愈为目的的肝切除术联合射频消融或微波消融治疗≤3cm CRLM 的患者。TO 根据最近基于德尔菲过程的肝外科定义定义,该定义还包括在 4 周时消融病灶/的完全放射学反应的实现。
2015 年至 2022 年期间,共纳入 112 例患者。其中,63 例(56.2%)达到了 TO。多因素分析显示,微创(MI)方法(OR 2.72,95%CI 0.99-7.48,p=0.050)、同期结直肠切除(OR 0.28,95%CI 0.11-0.70,p=0.007)、肿瘤负荷评分(OR 0.89,95%CI 0.82-0.96,p=0.004)和广泛肝切除术(OR 0.12,95%CI 0.03-0.52,p=0.004)与 TO 的实现显著相关。与未能达到 TO 的患者相比,达到 TO 的患者的中位总生存期更长。
肝切除术联合消融术在患有多发 CRLM 的患者中是一种有价值的解决方案,它可以提供足够的围手术期和肿瘤学结果,即使采用微创方法,也可以使患者达到 TO,但这需要在少数患者中,并取决于多种因素,包括疾病负担。